Skip to main content
Premium Trial:

Request an Annual Quote

Chris van Ingen

Chris van Ingen, a former member of Bruker's board of directors, died on June 27, Bruker said in a document filed with the US Securities and Exchange Commission. van Ingen died less than a week after he told the firm that he would be retiring from the board due to medical reasons. The cause of his death was not disclosed. He had been on Bruker's board since 2012. From 2001 to 2007, van Ingen was with Agilent Technologies where he served as president of the firm's bio-analytical measurement business.

The Scan

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.

US Survey Data Suggests Ancestry Testing Leads Way in Awareness, Use of Genetic Testing Awareness

Although roughly three-quarters of surveyed individuals in a Genetics in Medicine study reported awareness of genetic testing, use of such tests was lower and varied with income, ancestry, and disease history.

Coral Genome Leads to Alternative Amino Acid Pathway Found in Other Non-Model Animals

An alternative cysteine biosynthesis pathway unearthed in the Acropora loripes genome subsequently turned up in sequences from non-mammalian, -nematode, or -arthropod animals, researchers report in Science Advances.

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.